跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 91,704 条关于
“Measurable Residual Disease”
全部
91,704
临床试验
68,666
药物
1,417
机构
167
资讯
21,454
2年前
Pre-Transplant MRD Status Significantly Impacts Survival Outcomes in AML and MDS Patients
5年前
NGS-MRD Monitoring Predicts Relapse Risk in AML Patients Post-Transplant
3年前
MRD Assessment in Myeloma Trials Shows Increasing Use but Lacks Standardization
9个月前
Measurable Residual Disease Validated as Strong Predictor of Survival in AML Patients
2个月前
Measurable Residual Disease as Surrogate Endpoint in CLL Trials: Methodological Concerns Raised Over Meta-Analysis Findings
去年
Clinical Trials Target Residual Disease to Improve AML Outcomes
7个月前
Quest Diagnostics Launches Noninvasive Blood Test for Multiple Myeloma Residual Disease Monitoring
6年前
MRD Monitoring Predicts Relapse Risk Post-Allo-HSCT in AML Patients
9个月前
Adaptive Biotechnologies' clonoSEQ MRD Test Featured in Record 89 Abstracts at ASH 2025
去年
Huntsman Cancer Institute Joins myeloMATCH to Advance Precision Medicine for Blood Cancers
第 1 页，共 2146 页
上一页
下一页
